RSC Advances
Paper
5-Hexyl-1,3-bis(4-methoxyphenyl)-4H-thieno[3,4-c]pyrrole- General procedure for Table 3
4,6(5H)-dione (3r). The title compound was prepared from 1a
To a solution of Pd(OAc)2 (10 mol%), P(m-tolyl)3 (20 mol%), and
Cs2CO3 (2.40 mmol) in toluene (3 mL) in a ame-dried Schlenk
tube (20 mL) were added TPD 1b or FPD 1c (1.00 mmol) and the
corresponding aryl bromides (2.50 mmol) under N2. The reac-
tion mixture was then heated at 110 ꢀC under N2 for 24 h. Aer
the reaction mixture had cooled to room temperature, water
(10 mL) was added. The mixture was extracted with ethyl acetate
(2 ꢂ 30 mL), and the combined organic layers were washed with
brine (50 mL), dried (Na2SO4) and concentrated in vacuo. Puri-
cation by ash chromatography (ethyl acetate–hexane) yielded
the desired products 4a–d, 5a–b.
Diethyl 4,40-(5-(2-ethylhexyl)-4,6-dioxo-5,6-dihydro-4H-thieno-
[3,4-c]pyrrole-1,3-diyl) dibenzoate (4a). The title compound was
prepared from 1b (265 mg, 1.00 mmol) and ethyl 4-bromo-
benzoate (2b) (573 mg, 2.50 mmol) according to the general
procedure for Table 3 and yielding aer column chromatog-
raphy (ethyl acetate–hexane ¼ 10 : 90) the pure product 4a
(477 mg, 85%). A pale yellow solid; m.p.: 140.6–142.6 ꢀC. 1H
NMR (CDCl3, 300 MHz, ppm): d 8.17 (d, J ¼ 8.4 Hz, 4H), 8.09 (d,
J ¼ 8.4 Hz, 4H), 4.38 (q, J ¼ 7.1 Hz, 4H), 3.54 (d, J ¼ 7.2 Hz, 2H),
1.75–1.89 (m, 1H), 1.18–1.49 (m, 14H), 0.82–0.98 (m, 6H); 13C
NMR (CDCl3, 75 MHz, ppm): d 165.5, 162.6, 143.6, 134.0, 131.7,
131.4, 129.9, 127.8, 61.1, 42.5, 38.2, 30.5, 28.4, 23.8, 22.9, 14.2,
14.0, 10.3; MS (EI, 70 ev): 561 (M+, 69%), 462 (63%), 449 (45%),
390 (34%), 57 (100%); HRMS (EI): calcd for C32H35NO6S:
561.2185%, found: 561.2181%.
(237 mg, 1.00 mmol) and 4-bromoanisole (2r) (468 mg, 2.50
mmol) according to the general procedure for Table 2 and
yielding aer column chromatography (ethyl acetate–hexane ¼
6 : 94) the pure product 3r (288 mg, 64%). A pale yellow solid;
m.p.: 135.5–136.0 ꢀC. 1H NMR (CDCl3, 300 MHz, ppm): d 8.09 (d,
J ¼ 8.9 Hz, 4H), 6.97 (d, J ¼ 8.9 Hz, 4H), 3.86 (s, 6H), 3.64 (t, J ¼
7.4 Hz, 2H), 1.60–1.72 (m, 2H), 1.20–1.45 (m, 6H), 0.88 (t, J ¼ 6.6
Hz, 3H); 13C NMR (CDCl3, 75 MHz, ppm): d 163.1, 160.9, 144.2,
129.6, 128.8, 123.5, 114.2, 55.4, 38.5, 31.4, 28.4, 26.6, 22.5, 14.0;
MS (EI, 70 ev): 449 (M+, 100%), 418 (3%), 378 (26%); HRMS (EI):
calcd for C26H27NO4S: 449.1661%, found: 449.1665%.
5-Hexyl-1,3-bis(2-methoxyphenyl)-4H-thieno[3,4-c]pyrrole-
4,6(5H)-dione (3s). The title compound was prepared from 1a
(237 mg, 1.00 mmol) and 2-bromoanisole (2s) (468 mg, 2.50
mmol) according to the general procedure for Table 2 and
yielding aer column chromatography (ethyl acetate–hexane ¼
1
15 : 85) the pure product 3s (360 mg, 80%). Viscous liquid. H
NMR (CDCl3, 300 MHz, ppm): d 8.32 (dd, J ¼ 7.8, 1.6 Hz, 2H),
7.32–7.44 (m, 2H), 7.10 (t, J ¼ 8.0 Hz, 2H), 7.00 (d, J ¼ 8.0 Hz,
2H), 3.91 (s, 6H), 3.65 (t, J ¼ 7.2 Hz, 6H), 1.60–1.75 (m, 2H), 1.24–
1.41 (m, 6H), 0.89 (t, J ¼ 6.8 Hz, 3H); 13C NMR (CDCl3, 75 MHz,
ppm): d 163.1, 156.0, 141.2, 131.3, 130.8, 130.2, 120.6, 119.7,
111.1, 55.4, 38.1, 31.3, 28.3, 26.5, 22.4, 13.9; MS (EI, 70 ev): 449
(M+, 100%), 417 (6%), 378 (35%); HRMS (EI): calcd for
C
26H27NO4S: 449.1661%, found: 449.1663%.
1,3-Bis(4-(diphenylamino)phenyl)-5-hexyl-4H-thieno[3,4-c]-
5-(2-Ethylhexyl)-1,3-bis(4-(triuoromethyl)phenyl)-4H-thieno-
[3,4-c]pyrrole-4,6(5H)-dione (4b). The title compound was
prepared from 1b (265 mg, 1.00 mmol) and 4-bromobenzotri-
uoride (2j) (563 mg, 2.50 mmol) according to the general
procedure for Table 3 and yielding aer column chromatog-
raphy (ethyl acetate–hexane ¼ 1 : 99) the pure product 4b (354
pyrrole-4,6(5H)-dione (3t). The title compound was prepared
from 1a (237 mg, 1.00 mmol) and 4-bromotriphenylamine (2t)
(811 mg, 2.50 mmol) according to the general procedure for
Table 2 and yielding aer column chromatography (ethyl
acetate–hexane ¼ 4 : 96) the pure product 3t (478 mg, 66%). A
1
ꢀ
yellow solid; m.p.: 148.6–149.9 C. H NMR (CDCl3, 300 MHz,
ppm): d 7.97–8.05 (m, 4H), 7.27–7.38 (m, 8H), 7.00–7.23 (m,
16H), 3.64 (t, J ¼ 7.2 Hz, 2H), 1.60–1.74 (m, 2H), 1.21–1.45 (m,
6H), 0.89 (t, J ¼ 6.7 Hz, 3H); 13C NMR (CDCl3, 75 MHz, ppm): d
163.2, 149.4, 146.9, 144.2, 129.5, 129.1, 128.8, 125.4, 124.0,
123.8, 121.5, 38.5, 31.5, 28.5, 26.7, 22.5, 14.1; MS (FAB): 723 (M+,
100%), 141 (60%), 106 (90%); HRMS (FAB): calcd for
1
mg, 64%). A pale yellow solid; m.p.: 101.5–102.6 ꢀC. H NMR
(CDCl3, 300 MHz, ppm): d 8.25 (d, J ¼ 8.4 Hz, 4H), 7.74 (d, J ¼ 8.4
Hz, 4H), 3.57 (d, J ¼ 7.2 Hz, 2H), 1.75–1.93 (m, 1H), 1.20–1.44
(m, 8H), 0.83–0.98 (m, 6H); 13C NMR (CDCl3, 75 MHz, ppm): d
2
162.7, 143.3, 133.4, 132.0, 131.9 (q, JC,F ¼ 32 Hz), 128.3, 126.0
(q, 3JC,F ¼ 4 Hz), 123.7 (q, 1JC,F ¼ 271 Hz), 42.7, 38.3, 30.6, 28.6,
23.9, 23.0, 14.0, 10.4; MS (FAB): 554 ([M + 1]+, 67%), 534 (28%),
454 (100%), 424 (38%); HRMS (FAB): calcd for C28H25F6NO2S:
553.1510%, found: 553.1512%.
C
48H41N3O2S: 723.2919%, found: 723.2928%.
1-(1,2-Dihydropyren-1-yl)-3-(8,10-dihydropyren-1-yl)-5-hexyl-
4H-thieno[3,4-c]pyrrole-4,6(5H)-dione (3u). The title compound
was prepared from 1a (237 mg, 1.00 mmol) and 1-bromopyrene
(2u) (703 mg, 2.50 mmol) according to the general procedure for
Table 2 and yielding aer column chromatography (dichloro-
methane–hexane ¼ 30 : 70) the pure product 3u (453 mg, 71%).
A yellow solid; m.p.: 235.0–236.5 ꢀC. 1H NMR (CDCl3, 300 MHz,
ppm): d 8.55 (d, J ¼ 9.2 Hz, 2H), 7.96–8.49 (m, 16H), 3.66 (t, J ¼
7.5 Hz, 2H), 1.60–1.82 (m, 2H), 1.15–1.50 (m, 6H), 0.85 (t, J ¼ 6.6
Hz, 3H); 13C NMR (CDCl3, 75 MHz, ppm): d 162.7, 144.6, 132.6,
132.5, 131.2, 130.8, 129.2, 128.8, 128.7, 128.6, 127.2, 126.3,
126.0, 125.8, 124.9, 124.6, 124.49, 124.46, 124.2, 38.5, 31.3, 28.4,
26.6, 22.5, 14.0; MS (FAB): 637 (M+, 3%), 537 (2%), 141 (95%),
106 (100%); HRMS (FAB): calcd for C44H31NO2S: 637.2075%,
found: 637.2079%.
5-(2-Ethylhexyl)-1,3-di-p-tolyl-4H-thieno[3,4-c]pyrrole-4,6(5H)-
dione (4c). The title compound was prepared from 1b (265 mg,
1.00 mmol) and 4-bromotoluene (2n) (428 mg, 2.50 mmol)
according to the general procedure for Table 3 and yielding aer
column chromatography (ethyl acetate–hexane ¼ 5 : 95) the
pure product 4c (241 mg, 54%). A white solid; m.p.: 121.1–122.4
ꢀC. 1H NMR (CD2Cl2, 300 MHz, ppm): d 8.01 (d, J ¼ 7.8 Hz, 4H),
7.26 (d, J ¼ 7.8 Hz, 4H), 3.50 (d, J ¼ 7.0 Hz, 2H), 2.39 (s, 6H),
1.73–1.87 (m, 1H), 1.22–1.46 (m, 8H), 0.84–1.00 (m, 6H); 13C
NMR (CD2Cl2, 75 MHz, ppm): d 163.6, 144.9, 141.0, 130.4, 130.0,
128.5, 42.7, 38.9, 31.2, 29.2, 24.5, 23.6, 21.8, 14.5, 10.9; MS (EI,
70 ev): 445 (M+, 63%), 346 (72%), 333 (941%), 84 (100%); HRMS
(EI): calcd for C28H31NO2S: 445.2075%, found: 445.2080%.
35876 | RSC Adv., 2014, 4, 35868–35878
This journal is © The Royal Society of Chemistry 2014